Zobrazeno 1 - 10
of 1 089
pro vyhledávání: '"Pei Jer Chen"'
Autor:
Yu-Ping Chang, Chiuan-Bo Huang, Jia-Horng Kao, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Pei-Jer Chen, Chun-Jen Liu, Chen-Hua Liu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Pre-treatment host and viral factors may affect serum ferritin levels in patients with hepatitis C virus (HCV) infection. We delineated pre-treatment factors associated with hyperferritinemia in these patients. 1682 eligible patients underwe
Externí odkaz:
https://doaj.org/article/ebf428ef3ee848c0830005c0c497ba6b
Publikováno v:
BioTechniques, Vol 50, Iss 1, Pp 52-57 (2011)
Herein we describe a simple platform for rapid DNA amplification using convection. Capillary convective PCR (CCPCR) heats the bottom of a capillary tube using a dry bath maintained at a fixed temperature of 95°C. The tube is then cooled by the surro
Externí odkaz:
https://doaj.org/article/245cf65e757a4454949e3fabc70ce7ef
Autor:
Huey-Huey Chua, Ya-Hui Chen, Li-Ling Wu, Hung-Chih Yang, Chia-Ray Lin, Huey-Ling Chen, Jia-Feng Wu, Mei-Hwei Chang, Pei-Jer Chen, Yen-Hsuan Ni
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 17, Iss 3, Pp 361-381 (2024)
Background & Aims: A long immune-tolerant (IT) phase lasting for decades and delayed HBeAg seroconversion (HBe-SC) in patients with chronic hepatitis B (CHB) increase the risk of liver diseases. Early entry into the immune-active (IA) phase and HBe-S
Externí odkaz:
https://doaj.org/article/bb45e15e83084c77b9e1b92944f5e2a9
Autor:
Hsin-Yun Wu, Tung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, Jia-Huei Tsai, Ming-Han Wei, Chieh-Chang Chen, Chien-Chih Tung, Jia-Horng Kao, Pei-Jer Chen
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 1, Pp 88-97 (2024)
Background and aims: Coronavirus disease 2019 (COVID-19) vaccines were rapidly implemented globally and vaccine-associated immune-related hepatitis was recently reported. We aim to investigate its impact in regions endemic of chronic hepatitis B (CHB
Externí odkaz:
https://doaj.org/article/d9660f192670472da0db06e0aabeb2a2
Autor:
Chen-Hua Liu, Yih-Sharng Chen, Meng-Kun Tsai, Sheoi-Shen Wang, Chih-Yuan Lee, Chuan-I Tsao, Chun-Jen Liu, Tung-Hung Su, Tai-Chung Tseng, Shang-Chin Huang, Jo-Hsuan Wu, Pei-Jer Chen, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 8, Pp 800-804 (2023)
Data are limited regarding the long-term durability of sustained virologic response (SVR) in solid organ transplant recipients who achieve SVR12 with direct-acting antivirals (DAAs) for hepatitis C virus (HCV). We reported the virologic outcomes in 4
Externí odkaz:
https://doaj.org/article/5a87f568b68c4877beef5b9b317aeba0
Autor:
Meng-Ju Lin, Tung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, Chi-Ling Chen, Jyh-Ming Liou, Tai-Chung Tseng, Chen-Hua Liu, Chun-Ming Hong, Pei-Jer Chen, Jia-Horng Kao
Publikováno v:
Journal of the Formosan Medical Association, Vol 122, Iss 7, Pp 564-573 (2023)
Background/purpose: Distinct hepatitis relapse has been observed after discontinuing entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy in chronic hepatitis B (CHB) patients. End-of-therapy (EOT) serum cytokines were compared and used for
Externí odkaz:
https://doaj.org/article/2d3aedfe41f741b3ab626b5406e1d37c
Autor:
Tai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, Fumitaka Suzuki, Chieh Chiang, Chun-Ming Hong, Hiromitsu Kumada, Wan-Ting Yang, Tung-Hung Su, Hung-Chih Yang, Chen-Hua Liu, Pei-Jer Chen, Jia-Horng Kao
Publikováno v:
JHEP Reports, Vol 6, Iss 1, Pp 100956- (2024)
Background & Aims: Risk scores have been designed to predict the development of hepatocellular carcinoma (HCC) in treatment-naive patients with chronic hepatitis B (CHB). However, little is known about their predictive accuracy in HBeAg-negative pati
Externí odkaz:
https://doaj.org/article/11c9ce8e1ecf47a7a1a62aefefc4a1ba
Autor:
Chi-Ling Chen, Wei-Shiung Yang, Hwai-I. Yang, Chuen-Fei Chen, Li-Yu Wang, Sheng-Nan Lu, Jia-Horng Kao, Pei-Jer Chen, Chien-Jen Chen
Publikováno v:
Liver Cancer, Pp 1-1 (2024)
Introduction: Our previous nested-case-control study demonstrated elevated adiponectin increased liver cirrhosis and HCC risk in HBV carriers. We extended the analysis to the whole REVEAL-HBV cohort to prospectively evaluate whether adiponectin direc
Externí odkaz:
https://doaj.org/article/1c441ad4383146f493932492327d0764
Autor:
Shiou-Hwei Yeh, Chiao-Ling Li, You-Yu Lin, Ming-Chih Ho, Ya-Chun Wang, Sheng-Tai Tseng, Pei-Jer Chen
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 15, Iss 4, Pp 921-929 (2023)
Hepatitis B virus (HBV) DNA integration is an incidental event in the virus replication cycle and occurs in less than 1% of infected hepatocytes during viral infection. However, HBV DNA is present in the genome of approximately 90% of HBV-related HCC
Externí odkaz:
https://doaj.org/article/1f47e2272efd426ba91b4dc49df806ba
Autor:
Chiao-Ling Li, Chia-Lang Hsu, You-Yu Lin, Ming-Chih Ho, Chi-Ling Chen, Tung-Ching Ho, Yung-Feng Lin, Shih-Feng Tsai, Sheng-Tai Tzeng, Chin-Fang Huang, Ya-Chun Wang, Shiou-Hwei Yeh, Pei-Jer Chen
Publikováno v:
Liver Cancer (2023)
Introduction: A set of genetic mutations to classify hepatocellular carcinoma (HCC) useful to clinical studies is an unmet need. Hepatitis B virus-related HCC (HBV-HCC) harbors a unique genetic mutation, namely the HBV integration, among other somati
Externí odkaz:
https://doaj.org/article/031608ce259b4f12ae2bc4141f930896